NEW YORK (GenomeWeb) – Vermillion reported after the close of the market on Monday a more-than-threefold increase in its first quarter revenues. 

For the three months ended March 31, the Austin, Texas-based bioanalytical solutions firm said that total revenues rose to $951,000 from $305,000 in the year-ago quarter. 

The firm notched $635,000 in product revenues, up from $191,000 in Q1 2014, and $316,000 in license revenues, up from $114,000 a year ago. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.